CRH : 'an attractive entry point' according to UBS
'We believe that the stock's recent pullback offers an attractive entry point into CRH. We expect forecasts to be maintained, as are results' says UBS.
CRH has confirmed its full-year adjusted Ebitda target of between $6.55 and $6.85 billion.
The group, which has completed a $2.1 billion acquisition in the Texas cement business, says it has identified potential synergies of $60 million on an annualized basis from the deal.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction